Ilya Yu. Barkov
Ilya Yu. Barkov has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Dmitry Yurievich Trofimov
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Akademika Oparina St., 4, 117997 Moscow, Russia
3 shared publications - Andrey Yu. Goltsov
Laboratory of Molecular Genetic Methods, Institute of Reproductive Genetics, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov, Ministry of Health of Russia, Moscow, Russian Federation
2 shared publications I. S. Mukosey
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
2 shared publications- Jekaterina Shubina
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
2 shared publications A. A. Bystritsky
Kulakov Natl Med Res Ctr Obstet Gynecol & Perinat, Moscow, Russia
1 shared publication- Andrey Sergeyevich Glotov
Department of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynaecology, and Reproductology, 199034 St. Petersburg, Russia
1 shared publication
Latest Publications
- 8 April 2021
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 70 (1) , 19-50
Current relevance of non-invasive prenatal study of cell-free fetal DNA in the mother’s blood and prospects for its application in mass screening of pregnant women in the Russian Federation
This review article offers an analysis of application of cell-free fetal DNA non-invasive prenatal screening test for chromosome abnormalities in the mothers blood in different countries. The diagnostic capacities of the method, its limitations, execution models and ethical aspects pertinent to its application are discussed. The data for the discordant results is shown and analyzed. The advantages of the genome-wide variant of cell-free fetal DNA analysis and the problems concerning its application in the mass screening are described. The main suggestion is to implement the contingent cell-free fetal DNA testing model for the common trisomies (for the chromosomes 21, 18 and 13) into the prenatal diagnostic screening programs in the Russian Federation. This novel model is based on the results of the mass combined first trimester prenatal screening in four federal subjects of the country completed by 2019 and is offered as an additional screening in the mid-level risk group (with cut-off from 1 : 100 to 1 : 500 or from 1 : 100 to 1 : 1000) defined according to the first trimester prenatal screening results. The basic requirements for the implementation of the contingent model in the Russian Federation are stated.
- 8 April 2021
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 70 (1) , 19-50
Current relevance of non-invasive prenatal study of cell-free fetal DNA in the mother’s blood and prospects for its application in mass screening of pregnant women in the Russian Federation
This review article offers an analysis of application of cell-free fetal DNA non-invasive prenatal screening test for chromosome abnormalities in the mothers blood in different countries. The diagnostic capacities of the method, its limitations, execution models and ethical aspects pertinent to its application are discussed. The data for the discordant results is shown and analyzed. The advantages of the genome-wide variant of cell-free fetal DNA analysis and the problems concerning its application in the mass screening are described. The main suggestion is to implement the contingent cell-free fetal DNA testing model for the common trisomies (for the chromosomes 21, 18 and 13) into the prenatal diagnostic screening programs in the Russian Federation. This novel model is based on the results of the mass combined first trimester prenatal screening in four federal subjects of the country completed by 2019 and is offered as an additional screening in the mid-level risk group (with cut-off from 1 : 100 to 1 : 500 or from 1 : 100 to 1 : 1000) defined according to the first trimester prenatal screening results. The basic requirements for the implementation of the contingent model in the Russian Federation are stated.
- Open Access
- 15 June 2019
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 15-18
Detection of chromosomal rearrangements in the short arms of chromosomes 4 and 12 as an example of a whole-genome approach to noninvasive prenatal testing
Timely detection of fetal aneuploidy is an important aspect of clinical practice. At present, analytical techniques involving high-throughput sequencing are on the rise. Noninvasive prenatal testing (NIPT) ensures reliable results as early as week 9–11 into pregnancy. This article describes a clinical case of NIPT application and further verification of its results. Using next-generation sequencing, the microarray analysis of cell-free DNA in the amniotic fluid and the cytogenetic analysis of fetal chromosomes, a high risk of chromosomal rearrangements was detected in the short arms of chromosomes 4 and 12. This prediction was verified by molecular karyotyping conducted in both parents. The mother was found to be a balanced carrier of translocations between chromosomes 4 and 12. This case demonstrates the advantages of a whole-genome approach to NIPT over targeted-based.
- 15 June 2019
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 15-18
Open AccessDetection of chromosomal rearrangements in the short arms of chromosomes 4 and 12 as an example of a whole-genome approach to noninvasive prenatal testing
Timely detection of fetal aneuploidy is an important aspect of clinical practice. At present, analytical techniques involving high-throughput sequencing are on the rise. Noninvasive prenatal testing (NIPT) ensures reliable results as early as week 9–11 into pregnancy. This article describes a clinical case of NIPT application and further verification of its results. Using next-generation sequencing, the microarray analysis of cell-free DNA in the amniotic fluid and the cytogenetic analysis of fetal chromosomes, a high risk of chromosomal rearrangements was detected in the short arms of chromosomes 4 and 12. This prediction was verified by molecular karyotyping conducted in both parents. The mother was found to be a balanced carrier of translocations between chromosomes 4 and 12. This case demonstrates the advantages of a whole-genome approach to NIPT over targeted-based.
- Open Access
- 1 August 2018
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 30-34
Определение доли плодовой ДНК в плазме крови беременной женщины с помощью высокопроизводительного секвенирования набора частотных однонуклеотидных полиморфизмов
- 1 August 2018
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 30-34
Open AccessОпределение доли плодовой ДНК в плазме крови беременной женщины с помощью высокопроизводительного секвенирования набора частотных однонуклеотидных полиморфизмов
- Open Access
- 1 January 2018
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 29-33
Quantification of fetal DNA in the plasma of pregnant women using next generation sequencing of frequent single nucleotide polymorphisms
- 1 January 2018
- Published by Pirogov Russian National Research Medical University in Bulletin of Russian State Medical University
- No. 3,p. 29-33
Open AccessQuantification of fetal DNA in the plasma of pregnant women using next generation sequencing of frequent single nucleotide polymorphisms